How doctors report tumour deposits in rectal cancer scans
Part of Cancer, Digestive system clinical trials.
This study looks back at medical records to compare how MRI scans and lab tests describe tumour deposits (small clusters of cancer cells) in people with rectal cancer. It aims to improve how doctors report these deposits in the future, which may help guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with rectal cancer (confirmed by a biopsy).
- You had surgery to remove the cancer between January 2007 and December 2017, or between January 2022 and December 2024.
- You had an MRI scan and a post-surgery pathology report as part of your care.
- You are 16 years of age or older.
- You do not have cancer that has spread to other parts of the body (metastatic disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way of giving radiation therapy for rectal cancer, using MRI scans to aim the radiation more precisely. It's for people who need chemotherapy and radiation before surgery, and it aims to make treatment more effective while reducing side effects.
This trial tests whether an MRI scan done during chemoradiation can help doctors track how rectal cancer treatment is working. It may improve how they measure response early so treatment planning can be better tailored.
This Phase 1 study tests a radiation treatment approach guided by MRI scans to help keep nearby organs functioning while treating rectal cancer. It is designed to find a safe, effective way to target the tumor and adjust treatment during the course of therapy.
This study looks at how well cancer found on scans matches the actual cancer seen under the microscope after surgery. It may help improve how doctors plan treatment for colon, sigmoid, or rectal adenocarcinoma.
This trial reviews MRI scans and pathology reports from people with rectal cancer to improve how the disease is diagnosed and treated. It may help doctors better plan care for future patients.
This trial uses a special MRI before treatment to better understand early rectal cancer or suspicious large polyps. It may help doctors choose care that avoids bigger surgery when possible.
Hear when a new Rectal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.